Status:
NOT_YET_RECRUITING
Study of Leukocyte Populations in Patients With Chronic Inflammatory
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Systemic Autoimmune Disease
Chronic Inflammatory Rheumatism
Eligibility:
All Genders
18+ years
Brief Summary
Exploration of pathophysiological mechanisms in chronic inflammatory rheumatism and rare systemic autoimmune diseases with the objective of identifying therapeutic targets.
Detailed Description
The primary objective is to characterization of the quantitative and qualitative specificities of the different leukocyte sub-populations in patients with chronic inflammatory rheumatism and rare syst...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Patient who did not express his opposition
- Patients with chronic inflammatory rheumatism and rare systemic autoimmune diseases (pSS, lupus, scleroderma, myositis, unclassified connectivitis) diagnosed according to the usual criteria.
- Weight\> 35 kg
Exclusion
- Corticosteroid treatment\> 10 mg / day
- Pregnant patient
- Patients under legal protection
- Beneficiary of the state medical aid
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04749875
Start Date
March 1 2021
End Date
March 1 2026
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bicêtre
Le Kremlin-Bicêtre, France, 94275